Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
GALR1 (human)

Overview
GALR1 Receptor for the hormone galanin. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity. Belongs to the G-protein coupled receptor 1 family. Note: This description may include information from UniProtKB.
Protein type: Receptor, GPCR; Membrane protein, multi-pass; GPCR, family 1; Membrane protein, integral
Chromosomal Location of Human Ortholog: 18q23
Cellular Component: integral to membrane; plasma membrane
Molecular Function: neuropeptide binding; protein binding; peptide hormone binding; galanin receptor activity
Biological Process: positive regulation of cortisol secretion; elevation of cytosolic calcium ion concentration; neuropeptide signaling pathway; digestion; negative regulation of adenylate cyclase activity; positive regulation of transcription from RNA polymerase II promoter; G-protein signaling, adenylate cyclase activating pathway
Reference #:  P47211 (UniProtKB)
Alt. Names/Synonyms: GAL1-R; galanin receptor 1; Galanin receptor type 1; GALNR; GALNR1; GALR-1; GALR1
Gene Symbols: GALR1
Molecular weight: 38,953 Da
Basal Isoelectric point: 9.55  Predict pI for various phosphorylation states
Select Structure to View Below

GALR1

Protein Structure Not Found.


STRING  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  Phospho.ELM  |  NetworKIN  |  UCSD-Nature  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene  |  InnateDB


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 2 S143-p AIVHSRRssSLRVSR
0 2 S144-p IVHSRRssSLRVSRN
0 2 Y209-p VCTFVFGyLLPLLLI
0 2 Y220-p LLLICFCyAKVLNHL
  mouse

 
S143 AIVHSRRSSSLRVSR
S144 IVHSRRSSSLRVSRN
Y208 VCTFVFGYLLPLLLI
Y219 LLLICFCYAKVLNHL
  rat

 
S142 AIVHSRRSSSLRVSR
S143 IVHSRRSSSLRVSRN
Y207 VCTFVFGYLLPLLLI
Y218 LLLICFCYAKVLNHL
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.